Black Rifle Coffee is upgraded to 'Neutral' as coffee prices soften, reducing a key profit headwind. Here's what investors ...

BRC’s fair value price target is held at $2.50 per share, with no adjustment to the underlying valuation in this latest update. Bullish and bearish analysts are split on what this stable target means ...

BRC Therapeutics (BRC), a pharmaceutical company developing therapeutics for neurological and inflammatory diseases, ...

Why BRC-Approved Freeze-Dried Apple Production Builds Trust in Global Retail Channels. In a highly competitive retail ...

BRC Inc. is facing concerns over operational efficiency and profitability, but is working on a path to profitability in 2023. The company is expanding its wholesale distribution into the Food, Drug & ...